First-Line Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Real-World Outcomes and Prognostic Factors From a Vietnamese Cohort
mFOLFIRINOX regimen demonstrated efficacy and manageable toxicity in Vietnamese patients with metastatic pancreatic cancer. An individualized approach involving treatment interruptions was observed in patients with relatively favorable outcomes. These findings support the feasibility of the regimen in real-world settings.
Authors
- Thang Q. Tran
- Cuc Thi Hoang
- Huy Van Nguyen
- Phuong Thi Dinh
Institutions
- Vietnam National Children's Hospital (VN)
- Khanh Hoa General Hospital (VN)
Publication Details
- Journal
- Clinical Medicine Insights Oncology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1177/11795549261426101
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00